Adapting Treatment Delivery to Improve Retention in Evidence-Based PTSD Treatment
NCT ID: NCT06335589
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2024-06-24
2025-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course
NCT06957067
Enhancing Memory in CPT for PTSD
NCT06000475
Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families
NCT03256227
Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD
NCT02449421
Brief Treatment for Posttraumatic Stress Disorder
NCT03033602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EBP-Massed
PTSD evidence-based psychotherapies are delivered in a massed format (e.g., intended be delivered at least three times per week).
EBP-Massed
CPT or PE will be delivered in a massed format (e.g., sessions at least 3 days per week)
EBP-TAU
PTSD evidence-based psychotherapies are delivered treatment as usual, which is typically once per week.
EBP-TAU
CPT or PE will be delivered treatment as usual, which is typically once per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EBP-Massed
CPT or PE will be delivered in a massed format (e.g., sessions at least 3 days per week)
EBP-TAU
CPT or PE will be delivered treatment as usual, which is typically once per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* meets criteria for current PTSD;
* willingness to be randomized to either condition (e.g., EBP-Massed or EBP-TAU);
* decision to receive CPT or PE in a treatment planning session with a Durham Trauma Recovery Program clinic provider;
* ability to provide informed consent
Exclusion Criteria
* active manic symptoms that would likely interfere with treatment;
* active psychotic symptoms that would likely interfere with treatment;
* currently in a concurrent trauma-focused evidence-based treatment for PTSD
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Y Wells, PhD MS BA
Role: PRINCIPAL_INVESTIGATOR
Durham VA Medical Center, Durham, NC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDX 24-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.